The clinical utility of visual evaluation of scintigraphic perfusion patterns for Alzheimer's disease using I-123 IMP SPECT

Clinical Nuclear Medicine

Volumn 21, Issue 2, 1996, Pages 106-110

  Ishii, Kazunari ^a   Mori, Etsuro ^a   Kitagaki, Hajime ^a   Sakamoto, Setsu ^a   Yamaji, Shigeru ^a   Imamura, Toru ^a   Ikejiri, Yoshitaka ^a   Kono, Michio ^b  

^a Hyogo Inst Aging Brain Cogn D   (Japan)

^b KOBE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; IOFETAMINE I 123;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN PERFUSION; BRAIN SCINTIANGIOGRAPHY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE RECONSTRUCTION; MAJOR CLINICAL STUDY; MALE; RADIOISOTOPE DISTRIBUTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0030027372     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-199602000-00005     Document Type: Article

References (14)

1. Frackowiak RSJ, Pozzilli C, Legg NJ, et al: Regional cerebral oxygen supply and utilization in dementia: A clinical and physiological study with oxygen-15 and positron tomography. Brain 104:753, 1981.
2. Friedland RP, Budinger TF, Ganz E, et al: Regional cerebral metabolic alterations in dementia of the Alzheimer type: Positron emission tomography with [F-18] fluorodeoxyglucose. J Comput Assist Tomogr 7:590, 1983.
3. De Leon MJ, Ferris SH, George AE, et al: Computed tomography and positron emission transaxial tomography evaluations of normal aging and Alzheimer's disease. J Cereb Blood Flow Metab 3:391, 1983.
4. Friedland RP, Brun A, Budinger TF: Pathological and positron emission tomographic correlation in Alzheimer's disease. Lancet 1:228, 1985.
5. Burns A, Philpot MP, Costa DC, et al: The investigation of Alzheimer's disease with single photon emission tomography. J Neurol Neurosurg Psychiatry 52:248, 1989.
6. Karbe H, Kertesz A, Davis J, et al: Quantification of functional deficit in Alzheimer's disease using a computer-assisted mapping program for Tc-99m HMPAO SPECT. Neuroradiology 36:1, 1994.
7. Gemmell HG, Sharp PF, Besson JAO, et al: A comparison of Tc-99m HMPAO and I-123 IMP cerebral SPECT images in Alzheimer's disease and multi-infarct dementia. Eur J Nucl Med 14:463, 1988.
8. Holman BJ, Johnson KA, Gerada B, et al: The scintigraphic appearance of Alzheimer's disease: A prospective study using technetium-99m-HMPAO SPECT. J Nucl Med 33:181, 1992.
9. McKhann G, Drachman D, Folstein M, et al: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34:939, 1984.
10. Chui HC, Victroff JI, Margolin D, et al: Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's disease Diagnostic and Treatment Centers. Neurology 42:473, 1992.
11. The Lund and Manchester Groups. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 57:416, 1994.
12. Adams RD, Victor M: Principles of Neurology, 4th ed. New York, McGraw Hill, 1989.
13. Coleman PD, Flood DG: Neuron numbers and dendritic extent in normal aging and Alzheimer's disease. Neurobiol Aging 8:521, 1987.
14. Okazaki Y, Hashikawa K, Tanabe H, et al: Significance of hippocampal blood flow in the diagnosis of Alzheimer's disease: Survey by means of SPECT images longitudinal parallel to the hippocampus. (abstr) J Nucl Med 33(Suppl):940, 1992.